- Home
- CR vs HSIC Comparison
CR vs HSIC Comparison
Compare CR & HSIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CR | HSIC |
|---|---|---|
| Founded | 1855 | 1932 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.5B | 8.8B |
| IPO Year | N/A | 1995 |
Fundamental Metrics
Financial Performance| Metric | CR | HSIC |
|---|---|---|
| Price | $195.38 | $78.51 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 14 |
| Target Price | ★ $223.20 | $76.50 |
| AVG Volume (30 Days) | 270.3K | ★ 1.1M |
| Earning Date | 01-26-2026 | 02-24-2026 |
| Dividend Yield | ★ 0.47% | N/A |
| EPS Growth | ★ 37.96 | 30.70 |
| EPS | ★ 6.25 | 3.17 |
| Revenue | $2,268,100,000.00 | ★ $12,938,000,000.00 |
| Revenue This Year | $10.83 | $5.35 |
| Revenue Next Year | $14.14 | $3.34 |
| P/E Ratio | $31.11 | ★ $24.79 |
| Revenue Growth | ★ 19.64 | 3.51 |
| 52 Week Low | $127.04 | $60.56 |
| 52 Week High | $203.89 | $82.49 |
Technical Indicators
Market Signals| Indicator | CR | HSIC |
|---|---|---|
| Relative Strength Index (RSI) | 64.36 | 67.00 |
| Support Level | $183.16 | $75.31 |
| Resistance Level | $188.96 | $76.95 |
| Average True Range (ATR) | 3.87 | 1.30 |
| MACD | 0.63 | -0.06 |
| Stochastic Oscillator | 94.25 | 80.63 |
Price Performance
Historical ComparisonAbout CR Crane Company
Crane is a diversified industrial firm that manufactures a broad range of products, including valves, pumps, aerospace components, and fiberglass-reinforced plastic panels. Its business is organized into two segments: aerospace and electronics, and process flow technologies. Crane generated approximately $2.1 billion in revenue in 2024.
About HSIC Henry Schein Inc.
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology. It generates the majority of its revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.